Annual D&A
$863.00 K
+$66.00 K+8.28%
31 December 2023
Summary:
Aclaris Therapeutics annual depreciation & amortization is currently $863.00 thousand, with the most recent change of +$66.00 thousand (+8.28%) on 31 December 2023. During the last 3 years, it has fallen by -$461.00 thousand (-34.82%). ACRS annual D&A is now -86.53% below its all-time high of $6.41 million, reached on 31 December 2019.ACRS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$179.00 K
-$63.00 K-26.03%
30 September 2024
Summary:
Aclaris Therapeutics quarterly depreciation & amortization is currently $179.00 thousand, with the most recent change of -$63.00 thousand (-26.03%) on 30 September 2024. Over the past year, it has dropped by -$40.00 thousand (-18.26%). ACRS quarterly D&A is now -91.98% below its all-time high of $2.23 million, reached on 30 June 2019.ACRS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$892.00 K
-$40.00 K-4.29%
30 September 2024
Summary:
Aclaris Therapeutics TTM depreciation & amortization is currently $892.00 thousand, with the most recent change of -$40.00 thousand (-4.29%) on 30 September 2024. Over the past year, it has increased by +$67.00 thousand (+8.12%). ACRS TTM D&A is now -87.34% below its all-time high of $7.05 million, reached on 30 September 2019.ACRS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRS Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.3% | -18.3% | +8.1% |
| 3 y3 years | -34.8% | -6.3% | +222.0% |
| 5 y5 years | -54.1% | -89.0% | -87.3% |
ACRS Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -34.8% | +8.3% | -26.3% | at low | -4.3% | +222.0% |
| 5 y | 5 years | -86.5% | +8.3% | -89.0% | +139.9% | -87.3% | +222.0% |
| alltime | all time | -86.5% | +7745.4% | -92.0% | +139.9% | -87.3% | >+9999.0% |
Aclaris Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $179.00 K(-26.0%) | $892.00 K(-4.3%) |
| June 2024 | - | $242.00 K(-0.4%) | $932.00 K(+2.6%) |
| Mar 2024 | - | $243.00 K(+6.6%) | $908.00 K(+5.2%) |
| Dec 2023 | $863.00 K(+8.3%) | $228.00 K(+4.1%) | $863.00 K(+4.6%) |
| Sept 2023 | - | $219.00 K(+0.5%) | $825.00 K(+3.3%) |
| June 2023 | - | $218.00 K(+10.1%) | $799.00 K(+1.5%) |
| Mar 2023 | - | $198.00 K(+4.2%) | $787.00 K(-1.3%) |
| Dec 2022 | $797.00 K(-13.7%) | $190.00 K(-1.6%) | $797.00 K(-0.9%) |
| Sept 2022 | - | $193.00 K(-6.3%) | $804.00 K(+0.2%) |
| June 2022 | - | $206.00 K(-1.0%) | $802.00 K(-4.9%) |
| Mar 2022 | - | $208.00 K(+5.6%) | $843.00 K(-8.7%) |
| Dec 2021 | $923.00 K(-30.3%) | $197.00 K(+3.1%) | $923.00 K(+233.2%) |
| Sept 2021 | - | $191.00 K(-22.7%) | $277.00 K(-59.1%) |
| June 2021 | - | $247.00 K(-14.2%) | $677.00 K(-34.7%) |
| Mar 2021 | - | $288.00 K(-164.1%) | $1.04 M(-21.8%) |
| Dec 2020 | $1.32 M(-79.3%) | -$449.00 K(-176.0%) | $1.32 M(-36.7%) |
| Sept 2020 | - | $591.00 K(-2.5%) | $2.09 M(-33.2%) |
| June 2020 | - | $606.00 K(+5.2%) | $3.13 M(-34.1%) |
| Mar 2020 | - | $576.00 K(+80.0%) | $4.76 M(-25.7%) |
| Dec 2019 | $6.41 M | $320.00 K(-80.4%) | $6.41 M(-9.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $1.63 M(-26.8%) | $7.05 M(+21.5%) |
| June 2019 | - | $2.23 M(+0.2%) | $5.80 M(+49.3%) |
| Mar 2019 | - | $2.23 M(+132.4%) | $3.88 M(+106.7%) |
| Dec 2018 | $1.88 M(+367.4%) | $958.00 K(+149.5%) | $1.88 M(+70.5%) |
| Sept 2018 | - | $384.00 K(+21.9%) | $1.10 M(+32.1%) |
| June 2018 | - | $315.00 K(+41.9%) | $834.00 K(+45.3%) |
| Mar 2018 | - | $222.00 K(+22.7%) | $574.00 K(+42.8%) |
| Dec 2017 | $402.00 K(+235.0%) | $181.00 K(+56.0%) | $402.00 K(+54.0%) |
| Sept 2017 | - | $116.00 K(+110.9%) | $261.00 K(+47.5%) |
| June 2017 | - | $55.00 K(+10.0%) | $177.00 K(+18.8%) |
| Mar 2017 | - | $50.00 K(+25.0%) | $149.00 K(+24.2%) |
| Dec 2016 | $120.00 K(+33.3%) | $40.00 K(+25.0%) | $120.00 K(+6.2%) |
| Sept 2016 | - | $32.00 K(+18.5%) | $113.00 K(0.0%) |
| June 2016 | - | $27.00 K(+28.6%) | $113.00 K(+4.6%) |
| Mar 2016 | - | $21.00 K(-36.4%) | $108.00 K(+20.0%) |
| Dec 2015 | $90.00 K(+650.0%) | $33.00 K(+3.1%) | $90.00 K(+57.9%) |
| Sept 2015 | - | $32.00 K(+45.5%) | $57.00 K(+128.0%) |
| June 2015 | - | $22.00 K(+633.3%) | $25.00 K(+733.3%) |
| Mar 2015 | - | $3000.00 | $3000.00 |
| Dec 2014 | $12.00 K(+9.1%) | - | - |
| Dec 2013 | $11.00 K | - | - |
FAQ
- What is Aclaris Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Aclaris Therapeutics?
- What is Aclaris Therapeutics annual D&A year-on-year change?
- What is Aclaris Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Aclaris Therapeutics?
- What is Aclaris Therapeutics quarterly D&A year-on-year change?
- What is Aclaris Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Aclaris Therapeutics?
- What is Aclaris Therapeutics TTM D&A year-on-year change?
What is Aclaris Therapeutics annual depreciation & amortization?
The current annual D&A of ACRS is $863.00 K
What is the all time high annual D&A for Aclaris Therapeutics?
Aclaris Therapeutics all-time high annual depreciation & amortization is $6.41 M
What is Aclaris Therapeutics annual D&A year-on-year change?
Over the past year, ACRS annual depreciation & amortization has changed by +$66.00 K (+8.28%)
What is Aclaris Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of ACRS is $179.00 K
What is the all time high quarterly D&A for Aclaris Therapeutics?
Aclaris Therapeutics all-time high quarterly depreciation & amortization is $2.23 M
What is Aclaris Therapeutics quarterly D&A year-on-year change?
Over the past year, ACRS quarterly depreciation & amortization has changed by -$40.00 K (-18.26%)
What is Aclaris Therapeutics TTM depreciation & amortization?
The current TTM D&A of ACRS is $892.00 K
What is the all time high TTM D&A for Aclaris Therapeutics?
Aclaris Therapeutics all-time high TTM depreciation & amortization is $7.05 M
What is Aclaris Therapeutics TTM D&A year-on-year change?
Over the past year, ACRS TTM depreciation & amortization has changed by +$67.00 K (+8.12%)